A peptide consisting of 10 amino acids derived from the CH3 region of human IgG was shown to bind to monocytes and to inhibit rosette formation of antibody-coated erythrocytes with human monocytes. Two myeloma proteins of the IgG1 and IgG3 subclass, both with known deletions in the CH2 region of the gamma chain, showed unimpaired ability to bind to monocytes. These experiments suggest that the isolated peptide represents the primary site of attachment of IgG to monocytes.
gestion that the effector site is located in the CH3 region of the gamma chain. The present study was undertaken to attempt further precise localization of the effector site for monocyte binding in the Fc fragment of IgG.
MATERIALS AND METHODS
Fractionation of IgG Peptides. Pooled human IgG was digested with papain (8) , and Fab and Fc fragments were separated by electrophoresis on cellulose in Tris-borate buffer at pH 9.2. Fc fragments were allowed to react with 10% cyanogen bromide in 70% formic acid prior to dialysis of the reaction mixture. Peptides in the dialysate were chromatographed into seven fractions on paper with a butanol: pyridine:acetic acid:H20 mixture in a ratio of 15:10:3:12. Peptide fractions, which were functionally active, were labeled with [125I Jiodinated 3-(4-hydroxy)phenylpropionic acid N-hydroxysuccinimide ester (9) . Radiolabeled peptides were further fractionated by chromatography on paper and thin-layer silicic acid in the same solvent system. Aminoacid analysis of acid-hydrolyzed peptides was carried out by the method of Moore and Stein (10 (11, 12) and the other of the IgG3 (13, 14) . Human IgG and both myeloma proteins were labeled with 125I-labeled 3-(4-hydroxy)phenylpropionic acid N-hydroxysuccinimide ester. Human serum albumin was also labeled by this technique. To measure the binding of these proteins to monocytes, equal volumes of labeled protein solution (100 Aug/ml) and Hanks' balanced salt solution were incubated with monocyte monolayers for 15 min at 370, then aspirated the fluid. The monolayers were then washed three times and subsequently lysed with distilled H20. The lysate was assayed for 125I in a scintillation counter. On other occasions, 5"Cr E or EA were incubated with the washed monolayer prior to lysis of the monolayer with distilled water. The lysate was assayed for 1251 and "Cr simultaneously in a scintillation counter. reconstituted in water to a concentration of 2.5 mg/ml. This peptide mixture inhibited rosette formation to the extent of 64%, 70%, and 78% in three different dialysates. Seven peptide fractions were separated from the peptide mixture by chromatography on paper. The RF ranges for each fraction are given in Table 1 . Each fraction could be resolved into four or five component peptides by high voltage electrophoresis. However, only Fractions 4 and 5 resulted in inhibition of rosette formation, whereas the other peptide fragments enhanced the formation of rosettes. Synthetic peptides containing glycine, such as glycyl-alanine, glycyl-lysine, or glycyl-glutamic acid, also produced comparable enhancement in the formation of rosettes on a standard monolayer. The peptides eluted in Fractions 4 and 5 were labeled with 125I-3-(4-hydroxy)phenylpropionic acid N-hydroxysuccinimide ester and applied to monocyte monolayers. The monolayers were incubated for 20 min at 370 and then washed with Hanks' balanced salt solution three times. IgG (15 mg/ml) was then added to the monolayers to elute adherent, radiolabeled peptides. The eluate was dialyzed, and the dialysate was rechromatographed on paper. The distribution of radioactivity eluted from the paper is shown in Fig. 1 . Three areas of radioactivity were found, only one (the shaded area) coinciding with the presence of a peptide. The other two areas represented radioactivity derived from degradation products of the ester used in labelling, but free of peptides. The radioactive peptide in the RF ranges of 0.65-0.8 was further chromatographed on silicic acid in order to separate the radiolabeled IgG peptide from nonlabeled peptides from the eluates of the monolayers and the chromatography paper. While contaminating peptides remained at the origin in the silicic acid chromatograms, a single radioactive spot was eluted that had an RF of 0.8. Its amino-acid content is given in Table 2 .
RESULTS

Inhibition of Rosette
The radioactive peptide eluted from silicic acid was tested for its capacity to inhibit rosette formation in four separate experiments. The in the CH2 region of IgG, as the active peptide from the CH3 region almost completely inhibits the binding of intact IgG.
The failure of IgG2 and IgG4, in addition to IgM and IgA, to exhibit the properties of cytophilic antibody, suggests critical differences in amino-acid residues in the effector region. One IgG4 myeloma protein which has been extensively subjected to sequence analysis displays a substitution of arginine for lysine at residue 409 and no other difference from the active peptide (16) . There are few areas of the Fc fragment that are as highly charged as the region in which the effector site for monocyte binding is localized. If the arginine for lysine substitution is indeed as critical as appears from the difference between the cytophilic property of IgG1 and IgG4, then the difference probably does not result from mere charge differences. Sequence information is not yet available for the comparable regions of IgG2 and IgG3 globulins for comparison.
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